Tocilizumab-induced hypofibrinogenemia: A report of 7 cases-Reference-Cited by-同舟云学术

Tocilizumab-induced hypofibrinogenemia: A report of 7 cases

Published:2017-05 Issue:3 Volume:84 Page:369-370
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Martis Nihal,Chirio David,Queyrel-Moranne Viviane,Zenut Marie-Christine,Rocher Fanny,Fuzibet Jean-Gabriel

Publisher

Elsevier BV

Subject

Rheumatology

Reference6 articles.

1. Adverse drug reaction monitoring: doing it the French way;Moore;Lancet,1985

2. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: Measure, a randomised, placebo-controlled study;McInnes;Ann Rheum Dis,2013

3. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial;Nishimoto;Arthritis Rheum,2004

4. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis;Hingorani;Lancet,2012

5. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab);Souri;Thromb Res,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of tocilizumab-induced hypofibrinogenemia in rheumatology practice: a retrospective, real-life, single-center experience;Rheumatology International;2024-09-12

2. Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis;Microorganisms;2024-08-16

3. Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database;Expert Opinion on Drug Safety;2024-03-27

4. Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia;Clinical Rheumatology;2024-03-18

5. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy;Rheumatology;2024-03-05